CN1958801A
|
|
Method for constructing interference plasmid of human fibrinogen hf12 shRNA, and pharmic usage
|
CN1709338A
|
|
Insulin sensitive-intensifying agent from plant and its preparing method and use
|
CN1710081A
|
|
Method for promoting ultrosonic mediated gene transfection by copolymer
|
CN1693454A
|
|
Hybridized tumour cell strain of anti hpatitis B virus surface antigen and its monoclonal antibody
|
CN1657632A
|
|
Combination adeno-associated virus of expression human CYP2J2 antigene and its preparation method
|
CN1657631A
|
|
Recombination adeno-associated virus of expression human antisense phospho lamban gene and its preparation method
|
CN1611289A
|
|
Supercritical carbon dioxide mugwort active substance extracting method
|
CN1510148A
|
|
Method for constructing detecting system of hepatitis type B virus DNA
|
CN1510144A
|
|
Establishment and use of hfg 12 prothrombin double chain RNA and oligonucleotide
|
CN1463594A
|
|
Method for building virus hepatitis mice model
|
CN1422958A
|
|
Human vascular endothelial growth factor and its polyclonal antibody preparation and method for constructing eukaryotic expression vector
|
CN1424057A
|
|
Chinese medicine immune regulator and its preparation and use in pharmacy
|
CN1417584A
|
|
Double-parameter cell period analysis method
|
CN1412303A
|
|
Recombinant gland related virus expressing human kallikrein, its preparation method and application
|
CN1302638A
|
|
Anti-infection Chinese medicine for clearing heat and detoxicating and its preparing process
|
CN1302637A
|
|
Medicinal material resisting against human cytomegalovirus and its application in preparing medicines
|
CN1078452A
|
|
Built-in anti-tuberculosis anti-cancer anti-inflammation slow released material
|
CN1044048A
|
|
Absorbable slow-solution medicinal membrane and preparation thereof
|